Sort
11,323 grants matching “glioblastoma”
Prediction of Chemoradiation response in Glioblastoma to individualize Therapy
$391,586Kenneth D Aldape · University Of Tx Md Anderson Can Ctr · P50 · FY2009 · CA
Selectivity and regulation of mRNA demethylation by iron-dependent dioxygenases
$391,554Jeffrey Scott Mugridge · University Of Delaware · R35 · FY2022 · GM
Elucidating the Role of Perivascular Niche in Glioblastoma Invasion and Therapeutic Resistance at Single Cell Resolution using Biomimetic Tumor Microenvironment Models
$391,489Mehdi Nikkhah · Arizona State University-Tempe Campus · R01 · FY2021 · NS
A CEST-MRI Reporter Gene for Image Guided Oncolytic Virotherapy
$391,481Christian T Farrar · Massachusetts General Hospital · R01 · FY2018 · CA
Statistical Methods and Validation Analyses for the Integration of External Data in Clinical Trials
$391,445Lorenzo Trippa · Dana-Farber Cancer Inst · R01 · FY2021 · LM
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas
$391,435Gregory Joseph Riggins · Johns Hopkins University · R01 · FY2021 · CA
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas
$391,435Gregory Joseph Riggins · Johns Hopkins University · R01 · FY2020 · CA
Neoantigen-specific Adoptive T Cell Therapy for Glioblastoma, IND-BB-13135, protocol submitted 04/25/2020
$391,420Gary W. Wood · Tvax Biomedical, Inc. · R01 · FY2025 · FD
Defining Therapeutic Paradigms Based on Molecular Profiling of GBM
$391,390Brian D. Ross · University Of Michigan At Ann Arbor · P01 · FY2017 · CA
Inhibition of the ALK Receptor Kinase
$391,333Georgetown University · R01 · FY2003 · CA
Reprogramming the Tumor Microenvironment to Improve Immunotherapy of Glioblastoma by Co-Targeting VEGF and Ang2
$391,317Dai Fukumura · Massachusetts General Hospital · R01 · FY2024 · NS
Selectivity and regulation of mRNA demethylation by iron-dependent dioxygenases
$391,301Jeffrey Scott Mugridge · University Of Delaware · R35 · FY2023 · GM
Macrophage-targeted lncRNA-regulating nanoparticles for glioblastoma treatment
$391,250Edjah Nduom · Emory University · R01 · FY2023 · NS
Macrophage-targeted lncRNA-regulating nanoparticles for glioblastoma treatment
$391,250Edjah Nduom · Emory University · R01 · FY2025 · NS
MRI-Photoacoustic-Raman Nanostars for Pre- and Intraoperative Multimodal Imaging
$391,243Moritz Florian Kircher · Sloan-Kettering Inst Can Research · R01 · FY2015 · EB
Small Molecule Activators of Procaspases as Anti-Cancer Agents
$391,184Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2019 · CA
Role of GAS41 in Human Cancer
$391,163Xiaobing Shi · Van Andel Research Institute · R01 · FY2018 · CA
Integration of neo-antigen vaccines and immune checkpoint therapy
$391,107Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2025 · CA
Integration of neo-antigen vaccines and immune checkpoint therapy
$391,107Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2021 · CA
Selectivity and regulation of mRNA demethylation by iron-dependent dioxygenases
$391,040Jeffrey Scott Mugridge · University Of Delaware · R35 · FY2024 · GM
In vivo Handheld Coherent Raman Scattering (CRS) Microscopy for Glioma Imaging
$391,001Xiaoliang Sunney Xie · Harvard University · R01 · FY2014 · EB
In vivo Handheld Coherent Raman Scattering (CRS) Microscopy for Glioma Imaging
$391,000Xiaoliang Sunney Xie · Harvard University · R01 · FY2016 · EB
BIOMOLECULAR ANALYSIS USING LIQUID CRYSTALS
$390,982Nicholas L Abbott · University Of Wisconsin-Madison · R01 · FY2012 · CA
Targeting macrophage reprogramming in glioblastoma
$390,937Peiwen Chen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · NS
A CEST-MRI Reporter Gene for Image Guided Oncolytic Virotherapy
$390,914Christian T Farrar · Massachusetts General Hospital · R01 · FY2020 · CA